20041328

Source:http://linkedlifedata.com/resource/pubmed/id/20041328

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008838, umls-concept:C0030705, umls-concept:C0246415, umls-concept:C0278498, umls-concept:C0282460, umls-concept:C0879262, umls-concept:C1519810, umls-concept:C1521750
pubmed:issue	4
pubmed:dateCreated	2010-7-15
pubmed:abstractText	We evaluated the activity and toxicity of docetaxel, cisplatin, and S-1 (DCS) combination chemotherapy in patients with unresectable metastatic gastric cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid, http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination), http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/Tegafur, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1432-0843
pubmed:author	pubmed-author:HirataKoichiK, pubmed-author:KatoJunjiJ, pubmed-author:KidaMasayaM, pubmed-author:KobuneMasayoshiM, pubmed-author:MiyanishiKojiK, pubmed-author:NiitsuYoshiroY, pubmed-author:OhnumaHiroyukiH, pubmed-author:OhtaHidetoshiH, pubmed-author:OkuboSyunichiS, pubmed-author:SagawaTamotsuT, pubmed-author:SatoTsutomuT, pubmed-author:SatoYasuhiroY, pubmed-author:SatoYasushiY, pubmed-author:ShintaniNaoakiN, pubmed-author:TakahashiYasuoY, pubmed-author:TakayamaTetsujiT, pubmed-author:TakimotoRishuR, pubmed-author:TanakaShingoS, pubmed-author:YamaguchiKojiK
pubmed:issnType	Electronic
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	721-8
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:20041328-Adult, pubmed-meshheading:20041328-Aged, pubmed-meshheading:20041328-Antimetabolites, Antineoplastic, pubmed-meshheading:20041328-Antineoplastic Agents, pubmed-meshheading:20041328-Antineoplastic Agents, Phytogenic, pubmed-meshheading:20041328-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20041328-Cisplatin, pubmed-meshheading:20041328-Dose-Response Relationship, Drug, pubmed-meshheading:20041328-Drug Combinations, pubmed-meshheading:20041328-Female, pubmed-meshheading:20041328-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:20041328-Humans, pubmed-meshheading:20041328-Kaplan-Meier Estimate, pubmed-meshheading:20041328-Male, pubmed-meshheading:20041328-Middle Aged, pubmed-meshheading:20041328-Neoplasm Invasiveness, pubmed-meshheading:20041328-Neoplasm Metastasis, pubmed-meshheading:20041328-Neutropenia, pubmed-meshheading:20041328-Oxonic Acid, pubmed-meshheading:20041328-Stomach Neoplasms, pubmed-meshheading:20041328-Survival Analysis, pubmed-meshheading:20041328-Taxoids, pubmed-meshheading:20041328-Tegafur, pubmed-meshheading:20041328-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.
pubmed:affiliation	Fourth Department of Internal Medicine, School of Medicine, Sapporo Medical University, South 1 West 16, Chuo-ku, Sapporo, Japan.
pubmed:publicationType	Journal Article, Multicenter Study, Clinical Trial, Phase II